This was just one case so people will be fair in noting the limited data. But I note others on these threads and other sites mentioning serious adverse effects yet to appear in Amgen's updated reports. (Maybe unrelated, maybe not but the trend for how side effects are first vehemently denied by the pharmaceutical industry before admitted to is a pattern it created. So let it take responsibility for our resulting skepticism about rosy claims and negatives printed in tiny, tiny font or spoken at hyperspace in commercials.)

"Romosozumab was not effective in preventing multiple spontaneous clinical vertebral fractures after denosumab discontinuation: A case report*
https://www.sciencedirect.com/science/article/pii/S2352187220300486